...
首页> 外文期刊>Frontiers in Public Health >Multi-Morbidity in the Older Person: An Examination of Polypharmacy and Socioeconomic Status
【24h】

Multi-Morbidity in the Older Person: An Examination of Polypharmacy and Socioeconomic Status

机译:老年人的多发病率:对多酚和社会经济地位的检查

获取原文

摘要

There has been increased focus on clinically managing multi-morbidity in the older population, but it can be challenging to find appropriate paradigm that addresses the socio-economic burden and risk for polypharmacy. The Commission on Social Determinants of Health (CSDH) has examined the need for institutional change and the parallel need to address the social causes of poor health. This study explored three potential interventions namely, meaningful information from electronic health records (EHR), social prescribing, and redistributive welfare policies from a person-centered perspective using the CARE (connecting, assessing, responding, and empowering) approach. Economic instruments that immediately redistribute state welfare and reduce income disparity such as direct taxation and conditional cash transfers could be adopted to enable older people with long-term conditions have access to healthcare services. Decreased socioeconomic inequality and unorthodox prescriptive interventions that reduce polypharmacy could mitigate barriers to effectively manage the complexities of multi-morbidity.
机译:在临床上管理旧人口中的多发病率,却有挑战性,找到适当的范式可能具有挑战性,以解决社会经济负担和多酚疾病风险。卫生社会决定因素委员会(CSDH)审查了对机构变革的必要性,并行需要解决贫困健康的社会原因。本研究探讨了三种潜在的干预措施,即使用护理(连接,评估,响应和赋权)方法,从电子健康记录(EHR),社会规定和再分配福利政策中有意义的信息。可以通过立即重新分配国家福利和减少直接税收和条件现金转移等收入差距的经济文书,以使老年人能够获得医疗保健服务。减少社会经济不平等和非正统的规范化干预措施,减少多酚省曲可以减轻障碍,以有效地管理多发性的复杂性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号